Strange and bittersweet. That’s how Claire Mazumdar describes her plan to step down from the top spot at Bicara, a biotech ...

Last year, 11 major M&A deals were signed with women-led biotechs. The industry is nowhere near on track to meet that bar for ...

It’s not enough for organizations to want scientists to think like entrepreneurs. They have to incentivize and reward for ...

Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company dedicated to developing therapeutics ...

Limited (Nasdaq: CUPR) (“Cuprina” or “the Company”), a biomedical company developing and marketing products for the chronic ...

CVRx, Inc. (NASDAQ: CVRX), a medical device company focused on developing, manufacturing and commercializing innovative ...

Phase 1 findings reinforce the potential of WRN inhibition as a synthetic lethal approach to treating MSI-high cancers Among ...

NIH funding provides non-dilutive capital to advance late-stage U.S. clinical development of zelpultide alfa Program builds ...

XYone Therapeutics, Inc. ("XYone"), a clinical-stage biotechnology company, announced that the first patient has been dosed ...

Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced positive topline results from its pivotal Phase III study of ...

Munich, Germany, September 29, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a ...

Former House Majority Leader and global business executive brings decades of public policy and private-sector experience to ...